Publications (2009 until present)


  1. Cesarman E, Damania B, Krown SE, Martin J, Bower M, Whitby D. Kaposi Sarcoma. Nature Reviews: Disease Primers January 31, 2019; 5(1):9.  PubMed link.
  2. Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, et al. Pre-vaccination Prevalence of Anogenital and Oral Human Papillomavirus in Young HIV-infected Men who have Sex with Men: An AIDS Malignancy Consortium (AMC-072) and Adolescent Trials Network for HIV/AIDS (ATN) Study. Papillomavirus Research. January 15, 2019; 7:52-61. PubMed link.
  3. Einstein MH, Ndlovu N. Lee J, Stier E, et al. Cisplatin and Radiation Therapy in HIV-Positive Women with Locally Advanced Cervical Cancer in Sub-Saharan Africa: A Phase II Study of the AIDS Malignancy Consortium. Gynecologic Oncology. February 15, 2019. PubMed link.
  4. Reid E, Suneja G, Ambinder RF, Ard K, Baiocchi R, Barta SK, Carchman E, Cohen A, Crysler OV, Gupta N, Gustafson C, Hall A, Johung KL, Klopp A, LaCasce AS, Lin C, Mehta A, Menon MP, Morgan D, Nathwani N, Noy A, Ratner L, Rizza S, Rudek MA, Sanchez J, Taylor J, Tomlinson B, Wang CJ, Yendamuri S, Dwyer MA; CGC, Freedman-Cass DA. AIDS-Related Kaposi Sarcoma, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network (JNCCN). February 2019; 17(2):171-189.  PubMed link.
  5. Atkinson TM, Palefsky J, Li Y, Webb A, Berry JM, Goldstone S, et al. Reliability and between-group stability of a health-related quality of life symptom index for persons with anal high-grade squamous intraepithelial lesions: an AIDS Malignancy Consortium Study (AMC-A03). Qual Life Res. 2019 Jan 7.  PubMed link.


  1. Hosseinipour MC, Kang M, Krown SE, Bukuru A, Umbleja T, Martin J, et al. As-Needed versus Immediate Etoposide Chemotherapy in Combination with Antiretroviral Therapy for Mild or Moderate AIDS-associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis. 2018 Jul 2;67(2):251-260.  PubMed link.
  2. Ramos JC, Sparano JA, Rudek MA, Moore PC, Cesarman E, Reid EG, et al. Safety and Preliminary Efficacy of Vorinostat with R-EPOCH in High-risk HIV-associated Non-Hodgkin’s Lymphoma (AMC-075). Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):180-190. PubMed link.
  3. Shanbhag S, Ambinder RF. Hodgkin lymphoma: A review and update on recent progress. CA: A Cancer Journal for Clinicians. CA Cancer J Clin. 2018 Mar;68(2):116-132. PubMed link.
  4. Burkhalter J, Atkinson T, Holland S, Shuk E, Webb A, Rogers M, et al. Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions (HSIL): AMC-A02. Value Health. 2018 Aug;21(8):984-992.  PubMed link.
  5. Ellsworth GB, Lensing SY, Ogilvie CB, Lee JY; Goldstone SE, Berry-Lawhorn JM, Jay N, Stier EA, Logan JS, Einstein MH, Saah A, Mitsuyasu RT, Aboulafia D, Palefsky JM, Wilkin TJ. A Delayed Dose of Quadrivalent Human Papillomavirus Vaccine Demonstrates Immune Memory in HIV-1 infected Men. Papillomavirus Res. 2018 May 26;6:11-14.  PubMed link.
  6. Goldstone S, Lensing SY, Stier E, Darragh T, Lee J, van Zante A, et al. A Randomized Clinical Trial of Infrared Coagulation Ablation versus Active Monitoring of Intra-anal High-grade Dysplasia in HIV-infected Adults: An AIDS Malignancy Consortium Trial. Clinical Infectious Diseases. July 27, 2018. Journal - In Process.  PudMed link.
  7. Shah UA, Chung EY, Giricz O, Pradhan K, Kataoka K, Gordon-Mitchell S, et al. North American ATLL has a Distinct Mutational and Transcriptional Profile and Responds to Epigenetic Therapies. Blood. August 13, 2018. Journal - In Process. PubMed link.
  8. Buck C, Ratner L, Tosato G. Oncogenic Viruses. In DeVita, Hellman, and Rosenberg (Eds.), DeVita, Hellman, and Rosenberg’s Cancer: Principles & Practice of Oncology 10th edition, (pp. 69-81). Philadelphia: PA: Lippincott, Williams & Wilkins.
  9. Suneja G. New NCCN Guidelines: Cancer Management in People Living With HIV. J Natl Compr Canc Netw 2018;16:597-599.PubMed link.


  1. Raghavendran A, Hernandez AL, Lensing S, Gnanamony M, Karthik R, Sivasubramanian M, Kannangai R, Abraham P, Mathai D, Palefsky JM. Genital Human Papillomavirus Infection in Indian HIV-seropositive Men who have Sex with Men. Sexually Transmitted Diseases. March 2017; 44(3):173-180.  PubMed link.
  2. Sparano JA, Lee JY, Palefsky J, Henry DH, Wachsman W, Rajdev L, Aboulafia D, Ratner L, Fitzgerald TJ, Kachnic L, Mitsuyasu R. Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial (AMC045). Journal of Clinical Oncology. March 2017; 35(7):727-733. PubMed link.
  3. Kahn J, Lee J, Belzer M, Palefsky JM, AIDS Malignancy Consortium and Adolescent Medicine Trials Network for HIV/AIDS Interventions. Most HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs About Safer Sexual Behaviors After Human Papillomavirus Vaccination. AIDS and Behavior. 2018 Jun;22(6):1826-1834.  PubMed link.
  4. Chinula L, Moses A, Gopal S. HIV-associated Malignancies in Sub-Saharan Africa: Progress, Challenges, and Opportunities. Current Opinion in HIV and AIDS. January 2017; 12(1):89-95. PubMed link.
  5. Oliver NT, Chiao EY. Malignancies in Women with HIV Infection. Current Opinion in HIV and AIDS. January 2017; 12(1):69-76. PubMed link.
  6. Palefsky JM. Human Papillomavirus-associated Anal and Cervical Cancers in HIV-infected Individuals: Incidence and Prevention in the Antiretroviral Therapy Era. Current Opinion in HIV and AIDS. January 2017; 12(1):26-30. PudMed link.
  7. Polizzotto MN, Mitsuyasu RT. Clinical and Scientific Challenges in HIV-associated Malignancies. Current Opinion in HIV and AIDS. January 2017; 12(1):1-5. PubMed link.
  8. Wang CJ, Sparano J, Palefsky JM. Human Immunodeficiency Virus/AIDS, Human Papillomavirus, and Anal Cancer. Surg Oncol Clin N Am. 2017 Jan;26(1):17-31. PubMed link.
  9. Janakiram M, Shah UA, Liu W, Zhao A, Schoenberg MP, Zang X. The Third Group of the B7-CD28 Immune Checkpoint Family: HHLA2, TMIGD2, B7x, and B7-H3. Immunol Rev. 2017 Mar;276(1):26-39.PubMed link.
  10. Schneider JW, Dittmer DP. Diagnosis and Treatment of Kaposi Sarcoma. Am J Clin Dermatol. 2017 Aug;18(4):529-539.PubMed link.
  11. Uldrick TS, Ison G, Rudek MA, Noy A, Schwartz K, Bruinooge S, et al. Modernizing Clinical Trial Eligibility Criteria: Recommendations of the American Society of Clinical Oncology-Friends of Cancer Research HIV Working Group. J Clin Oncol. 2017 Nov 20;35(33):3774-3780. PubMed link.
  12. Tan CRC, Barta SK, Lee J, Rudek MA, Sparano JA, Noy A. Combination Antiretroviral Therapy Accelerates Immune Recovery in Patients with AIDS-related Lymphoma Treated with EPOCH: A Comparison Within One Prospective Trial AMC-034. Leuk Lymphoma. 2018 Aug;59(8):1851-1860. PubMed link.
  13. Rubinstein PG, Moore PC, Rudek MA, Henry DH, Ramos JC, Ratner L, et al. Brentuximab Vedotin with AVD shows Safety, in the Absence of Strong CYP3A4 Inhibitors, in Newly diagnosed HIV-associated Hodgkin Lymphoma. AIDS. 2018 Mar 13;32(5):605-611. PubMed link.
  14. Wagner-Johnston ND, Lensing S, Noy A, Ratner L, Henry D, Lee JY, et al. High Frequency of Identical Clonal Immunoglobulin DNA in Pre-Treatment Tumor and Plasma from Untreated Patients with HIV-Associated Lymphoma: Prospective Multicenter Trial of the AIDS Malignancies Consortium (AMC 064). Leuk Lymphoma. 2017 Dec;58(12):2939-2942. PubMed link.


  1. Hernandez AL, Karthik R, Sivasubramanian M,  Raghavendran A, Gnanamony M, Lensing S, Lee JY, Kannagai R, Abraham P, Mathai D, Palefsky JM. Prevalence of Anal HPV Infection among HIV-positive Men who have Sex with Men in India. Journal of Acquired Immune Deficiency Syndrome. April 1, 2016; 71(4):437-43. doi: 10.1097/QAI.0000000000000855. PMCID: PMC4939069. PubMed link.
  2. Alvarnas JC, Le Rademacher J, Wang Y, Little RF, Akpek G, Ayala E, DevineS, Baiocchi R, Lozanski G, Kaplan L, Noy A, Popat U, Hsu J, Morris LE, Thompson J, Horowitz MH, Mendizabal A, Levine A, Krishnan A, Forman SJ, Navarro WH, Ambinder RF. Autologous Hematopoietic Cell Transplantation for HIV-related Lymphoma: Results of the (BMT CTN) 0803/(AMC) 071 Trial. Blood. August 25, 2016;128(8):1050-8.doi: 10.1182/blood-2015-08-664706. Epub June 13, 2016. PMCID: PMC5000843. PubMed link.
  3. Foster WR, Bischin A, Dorer R, Aboulafia DM. Human Herpesvirus type-8- associated large B Cell Lymphoma: A Non-serous extra-cavitary variant of primary effusion lymphoma in an HIV-infected man. A case report and review of the literature. Clinical Lymphoma, Myeloma and Leukemia. June 2016;16(6):311-21.doi: 10.1016/j.clml.2016.03.013. Epub April 1, 2016. PMCID: PMC5421557. PubMed link.


  1. Barta SK, Samuel M, Xue X, Lee JY, Mounier N, Ribera J, Spina M, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Remick SC, Noy A, Sparano JA. Changes in the Influence of Lymphoma- and HIV-specific Factors on Outcomes in AIDS-related Non-Hodgkin Lymphoma. Annals of Oncology. May 2015; 26(5):958-66. doi: 10.1093/annonc/mdv036. Epub January 28, 2015. [Epub ahead of print]. PMCID: PMC4405278. PubMed link.
  2. Stier EA, Sebring MC, Mendez AE, Trimble DD, Chiao E. Prevalence of Anal Human Papillomavirus Infection and Anal HPV-related Disorders in Women: A Systematic Review. American Journal of Obstetrics and Gynecology. March 19, 2015. pii: S0002-9378(15)00264-1. doi: 10.1016/j.ajog.2015.03.034. [Epub ahead of print]. PMCID: PMC4556545. PubMed link.
  3. Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L for the AIDS Malignancy Consortium. AMC-048: Modified CODOX-M/IVAC-Rituximab is Safe and Effective for HIV-Associated Burkitt Lymphoma. Blood. May 8, 2015. pii: blood-2015-01-623900. [Epub ahead of print]. PMCID: PMC4497960. PubMed link.
  4. Palefsky J, Berry M. Prevention of Anal Cancer -- Can We Do Better? Diseases of the Colon and Rectum. May 2015; 58(5):e76. doi: 10.1097/DCR.0000000000000354. PMCID: PMC4579322. PubMed link.
  5. Arvey A, Ojesina A, Pedamallu CS, Ballon G, Jung J, Duke F, Leoncini L, De Falco G, Bressman E, Tam W, Chadburn A, Meyerson M, Cesarman E. The Tumor Virus Landscape of AIDS-related Lymphomas. Blood. May 14, 2015; 125(20):e14-e22. Epub March 31, 2015. PMCID: PMC4432014. PubMed link.
  6. Epeldegui M, Lee JY, Martínez AC, Widney DP, Magpantay LI, Regidor D, Mitsuyasu R, Sparano JA, Ambinder RF, Martínez-Maza O. Predictive Value of Cytokines and Immune Activation Biomarkers in AIDS-related Non-Hodgkin Lymphoma Treated with Rituximab plus Infusional EPOCH (AMC-034 Trial). Clinical Cancer Research. Epub ahead of print, September 17, 2015. NIHMSID: NIHMS728183. PMCID: PMC Journal - In Process. PubMed link.
  7. Battaglia TA, Gunn CM, McCoy ME, Mu HH, Baranoski AS, Chiao EY, Kachnic LA, Stier EA. Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research. Women’s Health Issues. August 4, 2015. pii: S1049-3867(15)00096-1. doi: 10.1016/j.whi.2015.06.008. [Epub ahead of print]. NIHMSID: NIHMS: 707636. PubMed link.


  1. Rubinstein PG, Aboulafia DM, Zloza A. Malignancies in HIV/AIDS: From Epidemiology to Therapeutic Challenges. AIDS. February 20, 2014; 28(4):453-465. doi: 10.1097/QAD.0000000000000071. PMCID: PMC4501859. PubMed link.
  2. Rudek MA, Moore PC, Mitsuyasu RT, Dezube BJ, Aboulafia D, Gerecitano J, Sullivan R, Cianfrocca ME, Henry DH, Ratner L, Haigentz M, Dowlati A, Little RF, Ivy SP, Deeken JF. A Phase I/Pharmacokinetic Study of Sunitinib in Combination with Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-positive Patients with Cancer: AIDS Malignancy Consortium Trial AMC-061. Cancer. January 28, 2014. doi: 10.1002/cncr.28554. [Epub ahead of print]. PMCID: PMC4038645. PubMed link.
  3. Simon JR, Stier EA. If a Man Needs a Gynecologist, Will He Be Able to Find One? Annals of Internal Medicine. February 25, 2014. doi: 10.7326/M13-2990. [Epub ahead of print]. PMCID: PMC4031456. PubMed link.
  4. Gopal S, Achenbach CJ, Yanik E, Dittmer DP, Eron JJ, Engles EA. Moving Forward in HIV-Associated Cancer. Journal of Clinical Oncology. March 20, 2014; 32(9):876-80. doi: 10.1200/JCO.2013.53.1376. Epub February 18, 2014. PMCID: PMC3948093. PubMed link.
  5. Deperalta DK, Hoang MP, Tanabe KK. Approaches to Regional Nodes in Patients with Melanoma. Journal of Clinical Oncology. March 20, 2014; 32(9):881-885. doi: 10.1200/JCO.2013.52.3571. Epub February 10, 2014. PMCID: PMC Journal - In Process; Followed-up w/ Journal 6/3/15 & 7/31/15, 10/15/2015. PubMed link.
  6. Gopal S, Patel MR, Achenbach CJ, Yanik EL, Cole SR, Napravnik S, Burkholder GA, Mathews WC, Rodriguez B, Deeks SG, Mayer KH, Moore RD, Kitahata MM, Richards KL, Eron JJ. Lymphoma Immune Reconstitution Inflammatory Syndrome in the Center for AIDS Research Network of Integrated Clinical Systems Cohort. Clinical Infectious Diseases. July 15, 2014; 59(2):279-286. doi: 10.1093/cid/ciu270. Epub April 21, 2014. PMCID: PMC4102912. PubMed link.
  7. Yanik EL, Napravnik S, Cole SR, Achenbach CJ, Gopal S, Dittmer DP, Olshan AF, Kitahata MM, Mugavero MJ, Saag M, Moore RD, Mathews WC, Hunt P, Eron JJ. Relationship of Immunologic Response to Antiretroviral Therapy with Non-AIDS Defining Cancer Incidence. AIDS. April 24, 2014; 28(7):979-87.doi: 10.1097/QAD.0000000000000167. PMCID: PMC4040952. PubMed link.
  8. Beumer JH, Venkataramanan R, Rudek MA. Pharmacotherapy in Cancer Patients with HIV/AIDS. Clinical Pharmacology and Therapeutics. April 2014; 95(4):370-372. doi: 10.1038/clpt.2014.10. Epub January 17, 2014. PMCID: PMC4091903. PubMed link.
  9. Cesarman E. How Do Viruses Trick B Cells into Becoming Lymphomas? Current Opinion in Hematology. July 2014; 21(4):358-68. doi: 10.1097/MOH.0000000000000060. PMCID: PMC4126608. PubMed link.
  10. Bayraktar UD, Diaz LA, Ashlock B, Toomey N, Cabral L, Bayraktar S, Pereira D, Dittmer DP, Ramos JC. Zidovudine-Based Lytic-Inducing Chemotherapy for Epstein-Barr Virus-Related Lymphomas. Leukemia & Lymphoma. April 2014; 55(4):786-794. doi: 10.3109/10428194.2013.818142. Epub August 28, 2013. PMCID: PMC4134930. PubMed link.
  11. Krown SE, Borok MZ, Campbell TB, Casper C, Dittmer DP, Hosseinipour MC, Mitsuyasu RT, Mosam A, Orem J, Phipps WT. Stage-stratified Approach to AIDS-related Kaposi's Sarcoma: Implications for Resource-limited Environments. Journal of Clinical Oncology. August 10, 2014; 32(23):2512-3. doi: 10.1200/JCO.2014.55.8999. Epub July 7, 2014. PubMed link.
  12. Barta SK, Xue X, Wang D, Lee JY, Kaplan LD, Ribera J, Oriol A, Spina M, Tirelli U, Boue F, Wilson WH, Wyen C, Dunleavy K, Noy A, Sparano JA. ARL-IPI – A New Prognostic Score for AIDS-Related Lymphomas in the Rituximab-Era. Haematologica. August 22, 2014. pii: haematol.2014.111112. [Epub ahead of print]. PMCID: PMC4222464. PubMed link.
  13. Adebamowo CA, Casper C, Bhatia K, Mbulaiteye SM, Sasco AJ, Phipps W, Vermund SH, Krown SE. Challenges in the Detection, Prevention, and Treatment of HIV-associated Malignancies in Low- and Middle-income Countries in Africa. Journal of Acquired Immune Deficiency Syndromes. September 1, 2014; 67 Suppl 1:S17-26. doi: 10.1097/QAI.0000000000000255. PMCID: PMC4392880. PubMed link.
  14. Gopal S, Fedoriw Y, Montgomery ND, Kampani C, Krysiak R, Sanders MK, Dittmer DP, Liomba NG. Multicentric Castleman's Disease in Malawi. The Lancet. September 20, 2014; 384(9948):1158. doi: 10.1016/S0140-6736(14)61366-0. PMCID: PMC4470481. PubMed link.
  15. Hosseinipour M, Sweet K, Xiong J, Namarika D, Mwafongo A, Nyirenda M, Chiwoko L, Kamwendo D, Hoggman I, Lee J, Phiri S, Vahrson W, Damania B, Dittmer D. Viral Profiling Identifies Multiple Sub-types of Kaposi Sarcoma. mBio. September 23, 2014; 5(5). pii: e01633-14. doi: 10.1128/mBio.01633-14. PMCID: PMC4173763. PubMed link.
  16. Vishnu P, Dorer RP, Aboulafia DM. Immune Reconstitution Inflammatory Syndrome-Associated Burkitt Lymphoma After Combination Antiretroviral Therapy in HIV-Infected Patients. Clinical Lymphoma, Myeloma and Leukemia. October 2014; 15(1). doi: 10.1016/j.clml.2014.09.009. PMCID: PMC 4607473. PubMed link.


  1. Dittmer DP, Damania B. Kaposi Sarcoma Associated Herpesvirus Pathogenesis (KSHV)-An Update. Current Opinion in Virology. June 2013; 3(3):238-244. doi: 10.1016/j.coviro.2013.05.012. Epub June 13, 2013. PMCID: PMC3716290. PubMed link.
  2. Cillo AR, Krishnan A, Mitsuyasu RT, McMahon DK, Li S, Rossi JJ, Zaia JA, Mellors JW. Plasma viremia and cellular HIV-1 DNA persist despite autologous hematopoietic stem cell transplantation for HIV-related lymphoma. Journal of Acquired Immune Deficiency Syndromes. August 1, 2013; 63(4):438-441. doi: 10.1097/QAI.0b013e31828e6163. PMCID: PMC3699958. PubMed link.
  3. Gopal S, Krysiak R, Liomba NG, Horner MJ, Shores CG, Alide N, Kamiza S, Kampani C, Chimzimu F, Fedoriw Y, Dittmer DP, Hosseinipour MC, Hoffman IF. Early Experience After Developing a Pathology Laboratory in Malawi, with Emphasis on Cancer Diagnoses. PLoS One. August 7, 2013; 8(8):e70361. doi: 10.1371/journal.pone.0070361. eCollection 2013. PMID: 23950924. PMCID: PMC3737192. PubMed link.
  4. Barta SK, Xue X, Wang D, Tamari R, Lee JY, Mounier N, Kaplan LD, Ribera J, Spina M, Tirelli U, Weiss R, Galicier L, Boue F, Wilson WH, Wyen C, Oriol A, Navarro J, Dunleavy K, Little RF, Ratner R, Garcia O, Morgades M, Remick SC, Noy A, Sparano JA. Treatment Factors Affecting Outcomes in HIV-associated Non-Hodgkin Lymphomas: A Pooled Analysis of 1,546 Patients. Blood. November 7, 2013; 122(19): 3251-3262. doi: 10.1182/blood-2013-04-498964. Epub September 6, 2013. PMCID: PMC3821722. PubMed link.
  5. Shcherba M, Shuter J, Haigentz M Jr. Current Questions in HIV-associated Lung Cancer. Current Opinion in Oncology. September 2013; 25(5):511-7. doi: 10.1097/CCO.0b013e328363dfdb. PMCID: PMC3906041. PubMed link.
  6. Cesarman E. Pathology of Lymphoma in HIV. Current Opinion in Oncology. September 2013; 25(5):487-494. doi: 10.1097/01.cco.0000432525.70099.a4. PMCID: PMC4126602. PubMed link.
  7. Gantt S, Casper C, Ambinder RF. Insights into the Broad Cellular Effects of Nelfinavir and the HIV Protease Inhibitors Supporting their Role in Cancer Treatment and Prevention. Current Opinion in Oncology. September 2013; 25(5):495-502. doi: 10.1097/CCO.0b013e328363dfee. PMCID: PMC4029099. PubMed link.
  8. Mani D, Aboulafia DM. Screening Guidelines for Non-AIDS Defining Cancers in HIV-infected Individuals. Current Opinion in Oncology. September 2013; 25(5):518-25. doi: 10.1097/CCO.0b013e328363e04a. PMCID: PMC4581521. PubMed link.
  9. Tugizov SM, Herrera R, Chin-Hong P, Veluppillai P, Greenspan D, Berry JM, Pilcher CD, Shiboski CH, Jay N, Rubin M, Chein A, Palefsky JM. HIV-associated Disruption of Mucosal Epithelium Facilitates Paracellular Penetration by Human Papillomavirus. Virology. November 2013; 446(1-2):378-388. doi: 10.1016/j.virol.2013.08.018. Epub September 17, 2013. PMCID: PMC3809142. PubMed link.
  10. Epstein MM, Breen EC, Magpantay L, Detels R, Lepone L, Penugonda S, Bream JH, Jacobson LP, Martínez-Maza O, Birmann BM. Temporal Stability of Serum Concentrations of Cytokines and Soluble Receptors measured across Two Years in Low-risk HIV-Seronegative Men. Cancer Epidemiology, Biomarkers & Prevention. November 2013; 22(11):2009-15. doi: 10.1158/1055-9965.EPI-13-0379. Epub August 27, 2013. PMCID: PMC3829469. PubMed link.
  11. Sharma R, Efird JT, Chein A, Holly EA, Krajden M, Berry JM, Darragh TM, Jay N, Palefsky JM. Prevalence and Risk Factors for Neutralizing Antibodies to Human Papillomavirus Types 16 and 18 in HIV-positive Men who have Sex with Men. Journal of Acquired Immune Deficiency Syndromes. December 15, 2013; 64(5):479-487. doi: 10.1097/QAI.0b013e3182a7acd2. PMCID: PMC4287402. PubMed link.
  12. Salter ML, Lau B, Mehta SH, Go VF, Leng S, Kirk GD. Correlates of Elevated Interleukin-6 and C-reactive Protein in Persons with or at High Risk for HCV and HIV Infections. Journal of Acquired Immune Deficiency Syndromes. December 15, 2013; 64(5):488-95. doi: 10.1097/QAI.0b013e3182a7ee2e. PMCID: PMC3848037. PubMed link.
  13. Koon HB, Krown, SE, Lee JY, Honda K, Rapswanee S, Wang J, Aboulafia D, Reid EG, Rudek MA, Dezube BJ, Noy A. Phase II Trial of Imatinib in AIDS-associated Kaposi’s Sarcoma: AIDS Malignancy Consortium Protocol 042. Journal of Clinical Oncology. December 30, 2013. [Epub ahead of print]. PMCID: PMC3912327. PubMed link.
  14. Lee JY, Moore PC, Steliga MA. Do HIV-infected Non-Small Cell Lung Cancer Patients Receive Guidance-Concordant Care? Medical Care. December 2013; 51(12):1063-1068. doi: 10.1097/MLR.0000000000000003. PMCID: PMC4047713. PubMed link.
  15. Bhatt S, Ashlock BM, Toomey NL, Diaz LA, Mesri EA, Lossos IS, Ramos JC. Efficacious Proteasome/HDAC Inhibitor Combination Therapy for Primary Effusion Lymphoma. The Journal of Clinical Investigation. June 3, 2013; 123(6):2616-2628. doi: 10.1172/JCI64503. Epub May 1, 2013. PubMed link.
  16. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N Aboulafia D,  Einstein MH, Saah A, Darragh TM, Mitsuyasu R , Palefsky JM. High-grade Anal Intraepithelial Neoplasia among HIV-1-Infected Men Screening for a Multicenter Clinical Trial of a Human Papillomavirus Vaccine. HIV Clinical Trials. March-April 2013; 14(2):75-79. PubMed link.
  17. Stier EA, Goldstone SE, Einstein MH, Jay N, Berry JM, Wilkin T, Lee JY, Darragh TM, DaCosta M, Panther L, Aboulafia D, Palefsky JM. Safety and Efficacy of Topical Cidofovir to Treat High-grade Perianal and Vulvar Intraepithelial Neoplasia in HIV-positive Men and Women. AIDS. February 20, 2013; 27(4):545-551. PubMed link.
  18. Shiramizu B, Liang CY, Agsalda-Garcia M, Nagata I, Milne C, Zhu X, Killeen J, Berry JM, Goodman MT. Presence of High-risk Human Papillomavirus Genotype and Human Immunodeficiency Virus DNA in Anal High-grade and Low-grade Squamous Intraepithelial Lesions. AIDS Research and Human Retroviruses. January 2013; 29(1):178-181. PubMed link.
  19. Levine AM, Noy A, Lee J, Tam W, Ramos JC, Henry D, Parekh S, Reid E, Mitsuyasu R, Cooley T, Dezube B, Ratner L, Cesarman E, Tulpule A, for the AIDS Malignancy Consortium. Pegylated Liposomal Doxorubicin, Rituximab, Cyclosphophamide, Vincristine and Prednisone (DR-COP) in AIDS-Related Lymphoma:  AIDS Malignancy Consortium Study 047 [AMC-047]. Journal of Clinical Oncology. January 1, 2013; 31(1):58-64. PubMed link.


  1. Krown SE, Roy D, Lee, JY, Dezube BJ, Reid EG, Venkataramanan R, Han K, Cesarman E, Dittmer DP.  Rapamycin with Antiretroviral Therapy in AIDS-associated Kaposi Sarcoma: An AIDS Malignancy Consortium study. Journal of Acquired Immune Deficiency Syndromes. April 15, 2012; 59(5):447-454. Epub November 7, 2011. PubMed link.
  2. Shamay M, Hand N, Lemas MV, Koon HB, Krown SE, Wrangle J, Desai P, Ramos JC, Ambinder RF.  CpG methylation as a Tool to Characterize Cell-free Kaposi's Sarcoma Herpesvirus DNA.  2011. The Journal of Infectious Diseases. April 2012; 205(7):1095-9. Epub February 22, 2012. PubMed link.
  3. Rais R, Zhao M, He P, Xu L, Deeken JF, Rudek MA.  Quantitation of Unbound Sunitinib and its Metabolite N-desethyl Sunitinib (SU12662) in Human Plasma by Equilibrium Dialysis and Liquid Chromatography-tandem Mass Spectrometry: Application to a Pharmacokinetic Study.  Biomedical Chromatography. January 18, 2012. doi: 10.1002/bmc.2697. [Epub ahead of print]. PubMed link.
  4. Mani D, Haigentz M Jr., Aboulafia DM. Lung Cancer in HIV Infection. Clinical Lung Cancer. January 2012; 13(1):6-13. doi: 10.1016/j.cllc.2011.05.005. Epub July 29, 2011. PubMed link.


  1. Barta SK, Lee JY, Kaplan LD, Noy A, Sparano JA. Pooled Analysis of AIDS Malignancy Consortium Trials Evaluating Rituximab plus CHOP or Infusional EPOCH Chemotherapy in HIV-associated Non-Hodgkin Lymphoma. Cancer. December 16, 2011. doi: 10.1002/cncr.26723. [Epub ahead of print]. PubMed link.
  2. Dittmer DP. Restricted Kaposi Sarcoma (KS) Herpesvirus Transcription in KS Lesions from Patients on Successful Antiretroviral Therapy. American Society for Microbiology. November 1, 2011; 2(6):e00138-11. doi: 10.1128/mBio.00138-11. PubMed link.
  3. Rudek MA, Flexner C, Ambinder RF. Use of Antineoplastic Agents in Patients with Cancer who have HIV/AIDS.  The Lancet Oncology. September 2011; 12(9):905-912. Epub May 12, 2011. PubMed link.
  4. Roy D, Sin S-H, Damania B, Dittmer DP. Tumor Suppressor Genes FHIT and WWOX are deleted in Primary Effusion Lymphoma (PEL) Cell Lines. Blood. August 18, 2011; 118(7):e32-9. Epub June 17, 2011. PubMed link.
  5. Ramos JC, Sin SH, Staudt MR, Roy D, Vahrson W, Dezube BJ, Harrington W Jr, Dittmer DP. Nuclear Factor kappa B (NFkB) Pathway Associated Biomarkers in AIDS Defining Malignancies. International Journal of Cancer. July 25, 2011. PubMed link.
  6. Giulino L, Mathew S, Ballon G, Chadburn A, Barouk S, Antonicelli G, Leoncini L, Liu YF, Gogineni S, Tam W, Cesarman E. A20 (TNFAIP3) Genetic Alterations in EBV-associated AIDS-related Lymphoma. Blood. May 5, 2011; 117(18):4852-4854. Epub March 15, 2011. PubMed link.
  7. Wagner-Johnston ND, Gellert L, Gocke CD, Lemas MV, Lee J, Martinez-Maza O, Ambinder RF.   Clonal Immunoglobulin DNA in the Plasma of Patients with AIDS-lymphoma.  Blood. May 5 2011; 117(18):4860-4862. Epub March 9, 2011. PMCID: PMC3100695. PubMed link.
  8. Cianfrocca M, Lee S, Von Roenn J, Rudek MA, Dezube BJ, Krown SE, Sparano JA.  Pilot Study Evaluating the Interaction between Paclitaxel and Protease Inhibitors in Patients with Human Immunodeficiency Virus-associated Kaposi’s Sarcoma: An Eastern Cooperative Oncology Group (ECOG) and AIDS Malignancy Consortium (AMC) Trial.  Cancer Chemotherapy and Pharmacology. Epub January 5, 2011. PubMed link.
  9. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-related Kaposi Sarcoma. Journal of Acquired Immune Deficiency Syndromes. January 1, 2011; 56(1):64-68. PubMed link.


  1. Wilkin T, Lee JY, Lensing SY, Stier EA, Goldstone SE, Berry JM, Jay N, Aboulafia D, Cohn DL, Einstein MH, Mitsuyasu RT, Palefsky JM. Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men. Journal of Infectious Diseases. October 15, 2010; 202(8):1246-1253. PubMed link.
  2. Noy, A. Controversies in the Treatment of Burkitt Lymphoma in AIDS. Current Opinion in Oncology. September 2010; 22(5):443-448. PubMed link.
  3. Nagaiah G, Stotler C, Orem J, Mwanda WO, Remick SC. Ocular Surface Squamous Neoplasia in Patients with HIV Infection in Sub-Saharan Africa. Current Opinion in Oncology. September 2010; 22(5):437-442. PubMed link.
  4. Einstein MH, Phaëton R. Issues in Cervical Cancer Incidence and Treatment in HIV. Current Opinion in Oncology. September 2010; 22(5):449-455. PubMed link.
  5. Koon HB, Fingleton B, Lee JY, Geyer JT, Cesarman E, Parise RA, Egorin MJ, Dezube BJ, Aboulafia D, Krown SE. Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi’s Sarcoma. Journal of Acquired Immune Deficiency Syndrome. September 2010; 56:64-68. PubMed link.
  6. Cianfrocca M, Lee S, Von Roenn J, Tulpule A, Dezube BJ, Aboulafia DM, Ambinder RF, Lee JY, Krown SE, Sparano JA. Randomized Trial of Paclitaxel versus Pegylated Liposomal Doxorubicin for Advanced Human Immunodeficiency Virus-associated Kaposi’s Sarcoma: Evidence for Symptom Palliation from Chemotherapy. Cancer. August 15, 2010; 116(16):3969-77. PubMed link.
  7. Lock EF, Ziemiecki R, Marron J, Dittmer DP. Efficiency clustering for low-density microarrays and its application to QPCR. BMC Bioinformatics. July 20 2010; 11:386. PubMed link.
  8. Chiao EY, Dezube BJ, Krown SE, Wachsman W, Brock MV, Giordano TP, Mitsuyasu R, Pantanowitz L. Time for oncologists to opt in for routine opt-out HIV testing? JAMA. July 21 2010; 304:334-339. PubMed link.


  1. Sparano JA, Lee J, Kaplan LD, Levine A, Ramos JC, Ambinder R, Wachsman W, Aboulafia D, Noy A, Henry D, Von Roenn J, Dezube B, Remick S, Shah MH, Leichman L, Ratner L, Cesarman E, Chadburn A, Mitsuyasu R. Rituximab plus Concurrent Infusional EPOCH Chemotherapy is Highly Effective in HIV-Associated, B-cell Non-Hodgkin's Lymphoma. Blood. Epub December 18, 2009. PubMed link.
  2. Lechowicz MJ, Dittmer DP, Lee JY, Krown SE, Wachsman W, Aboulafia D, Dezube B, Ratner L, Said J, Ambinder RF. Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid. Clinical Infectious Diseases, Infectious Diseases Society of America. December 15, 2009; 49(12):1946-1949. PubMed link.
  3. Chadburn A, Chiu A, Lee JY, Chen X, Hyjek E, Banham AH, Noy A, Kaplan LD, Sparano JA, Bhatia K, Cesarman E. Immunophenotypic Analysis of AIDS-related Diffuse Large B-cell Lymphoma and Clinical Implications in Patients from AIDS Malignancies Consortium Clinical Trials 010 and 034. Journal of Clinical Oncology. Epub September 14, 2009. October 20, 2009; 27(30):5039-48. PubMed link.
  4. Palefsky JM. Anal Cancer Prevention in HIV-positive Men and Women. Current Opinion in Oncology. September 2009; 21(5): 433-438. PubMed link.
  5. Mwanda WO, Orem J, Fu P, Banura C, Kakembo J, Onyango CA, Ness A, Reynolds S, Johnson JL, Subbiah V, Bako J, Wabinga H, Abdallah FK, Meyerson HJ, Whalen CC, Lederman MM, Black J, Ayers LW, Katongole-Mbidde E, Remick SC. Dose-Modified Oral Chemotherapy in the Treatment of AIDS-related Non-Hodgkin’s Lymphoma in East Africa. Journal of Clinical Oncology, American Society of Clinical Oncology. Epub May 26, 2009. July 20, 2009;27(21):3480-8. PubMed link.
  6. O'Hara AJ, Wang L, Dezube BJ, Harrington WJ Jr, Damania B, Dittmer DP. Tumor Suppressor microRNAs are Underrepresented in Primary Effusion Lymphoma and Kaposi Sarcoma. Blood. Epub February 27, 2009. June 4, 2009. 113(23):5938-5941. PubMed link.
  7. Lin L, Lee JY, Kaplan LD, Dezube BJ, Noy A, Krown SE, Levine AM, Yu Y, Hayward GS, Ambinder RF. Effects of Chemotherapy in AIDS-associated Non-Hodgkin's Lymphoma on Kaposi's Sarcoma Herpesvirus DNA in Blood. Journal of Clinical Oncology. May 20, 2009; 27(15):2496-2502.  PubMed link.
  8. O’Hara AJ, Chugh P, Wang L, Netto EM, Luz E, Harrington WJ Jr, Dezube BJ, Damania B, Dittmer DP.  Pre-micro RNA Signatures Delineate Stages of Endothelial Cell Transformation in Kaposi Sarcoma.  PLoS Pathogens. Epub April 17, 2009. April 2009; 5(4):e1000389. PubMed link.
  9. Lu P, Yang C, Guasparri I, Harrington W, Wang YL, Cesarman E. Early Events of B-cell Receptor Signalling are not essential for the Proliferation and Viability of AIDS-related Lymphoma. Leukemia. Epub November 6, 2008. April 2009; 23(4):807-10. PubMed link.
  10. Gualco G, Queiroga EM, Weiss LM, Klumb CE, Harrington WJ Jr., Bacchi CE. Frequent Expression of Multiple Myeloma 1/Interferon Regulatory Factor 4 in Burkitt Lymphoma. Human Pathology. Epub January 13, 2009. April 2009; 40(4):565-571. PubMed link.
  11. Ratner L, Harrington W, Feng X, Grant C, Jacobson S, Noy A, Sparano J, Lee J, Ambinder R, Campbell N, Lairmore M, and the AIDS Malignancy Consortium. Human T-cell Leukemia Virus Reactivation with Progression of Adult T-cell Leukemia-Lymphoma. PLoS ONE. Epub February 10, 2009. 2009; 4(2):e4420. PubMed link.
  12. Pantanowitz L, Dezube BJ. Evolving Spectrum and Incidence of Non-AIDS-defining Malignancies. Current Opinion in HIV and AIDS. January 2009; 4(1):27-34. PubMed link.